BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Carol Wrenn Joins Heska Corporation (HSKA)'s Board of Directors


1/4/2013 6:56:24 AM

LOVELAND, Colo., Jan. 4, 2013 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA, "Heska" or the "Company"), a leading provider of veterinary diagnostic and specialty products, announced today that Carol Wrenn had joined Heska's Board of Directors.

Ms. Wrenn is a founder and current President of Sky River Helicopters, LLC. From 2001 to 2009, she was President of the Animal Health Division and an Executive Vice President of Alpharma Inc. During her tenure at Alpharma, Ms. Wrenn is credited for the turnaround and subsequent revenue and earnings growth of the Animal Health business. Prior to joining Alpharma, Ms. Wrenn held various executive positions at Honeywell International Inc. (formerly Allied Signal Inc.) from 1984 to 2001.

Ms. Wrenn currently serves on the Board of Phibro Animal Health Corporation. She chaired the Animal Health Institute from 2007 to 2009 and was a Board member of the International Federation of Animal Health (IFAH) from 2002 to 2009.

"I am pleased to join the talented Board Heska has assembled," commented Ms. Wrenn. "I am excited to assist Heska in its drive to offer veterinarians state-of-the-art products and enhance shareholder value."

"We are delighted to add a new Board member with such strong animal health credentials," said Robert Grieve, Heska's Chairman and Chief Executive Officer. "Her proven background in driving growth and creating value will be valuable to Heska and its shareholders as we continue to introduce new products and leverage our improving sales organization. We are always interested in pursuing new Board members who offer complementary skills and are glad Ms. Wrenn has agreed to join us."

About Heska

Heska Corporation (NASDAQ: HSKA) sells advanced veterinary diagnostic and other specialty veterinary products. Heska's state-of-the-art offerings to its customers include diagnostic instruments and supplies as well as single use, point-of-care tests, pharmaceuticals and vaccines. The Company's core focus is on the canine and feline markets where it strives to provide high value products and unparalleled customer support to veterinarians. For further information on Heska and its products, visit the company's website at www.heska.com.

Forward-Looking Statements

This announcement contains forward-looking statements regarding Heska's future financial and operating results. These statements are based on current expectations and are subject to a number of risks and uncertainties. There are uncertainties regarding the ability of any Board member, or the Board of Directors as a group, to impact Heska's operating and financial performance; uncertainties related to Heska's ability to recruit new Board members; uncertainties related to Heska's ability to retain its current Board members; and the risks set forth in Heska's filings and future filings with the Securities and Exchange Commission, including those set forth in Heska's Quarterly Report on Form 10-Q for the quarter ended September 30, 2012.

SOURCE Heska Corporation



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES